Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
June 18, 2008

Sanofi-Aventis Bids Against Anthiarose for Zentiva

  • Yesterday, Anthiarose, a subsidiary of PPF Group, reported a voluntary takeover offer to acquire Zentiva at $60.8 (CZK 950) a share.

    Today, Sanofi-Aventis, the largest Zentiva shareholder, presented a competing bid of $62.7 (CZK 1050) per share.

    Zentiva boasts over 280 products including prescription drugs, OTC products, and food supplements. The firm also manufactures cosmetics and APIs.
  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.